Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Zachary Herzwurm

Orthopaedic Surgery Temple Terrace, FL Medical Doctor

NPI 1487002184 CMS profile 2221390

13020 N Telecom Pkwy, Temple Terrace, FL 33637

Open in the dashboard

General payments

$11,594

127 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Zachary Herzwurm of Temple Terrace, FL is reported in the CMS Open Payments database as having received $11,594 across 127 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $561 7
2024 General $1,217 21
2023 General $3,560 40
2022 General $3,859 36
2021 General $675 6
2020 General $813 10
2019 General $909 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zachary Herzwurm
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Zachary Herzwurm were reported at $561. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Zachary Herzwurm Orthopaedic Surgery median Middle half National median
2019 $909 $644 $140–$2,844 $163
2020 $813 $312 $75–$1,860 $114
2021 $675 $520 $117–$2,495 $132
2022 $3,859 $598 $128–$2,731 $149
2023 $3,560 $461 $128–$2,264 $160
2024 $1,217 $497 $134–$2,475 $164
2025 $561 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $5,205 49 payments
  2. Medline Industries, Inc. $1,158 7 payments
  3. Medical Device Business Services, Inc. $1,011 5 payments
  4. Smith+Nephew, Inc. $819 16 payments
  5. Coastal Medical Technologies LLC $714 8 payments
  6. Arthrex, Inc. $617 11 payments
  7. Vericel Corporation $217 2 payments
  8. TissueTech, Inc. $209 2 payments
  9. Treace Medical Concepts, Inc. $206 2 payments
  10. Heraeus Medical, LLC. $174 2 payments
  11. Other $1,264 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,064 107 payments
  2. Travel and Lodging $3,498 14 payments
  3. Education $1,011 5 payments
  4. Gift $22 1 payment
Products named General payments · program years 2019–2025
  1. PROSTEP $1,989 13 payments
  2. INBONE $1,591 14 payments
  3. INFINITY $911 11 payments
  4. INVISION $897 7 payments
  5. PROPHECY $897 7 payments
  6. ORTHOLOC 2 LAPIFUSE $724 8 payments
  7. CITREFIX $444 4 payments
  8. EVOS $358 4 payments
  9. ACTISHIELD $318 4 payments
  10. TRIGEN INTERTAN $221 5 payments
  11. Other $2,973 48 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

328

Median for Orthopedic Surgery: 203

Drug cost

$1,132

Median for Orthopedic Surgery: $1,433

Branded share of claims

14.6%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 160 $326
Gabapentin Generic 47 $222
Ondansetron Hcl Generic 32 $170
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 31 $166
Diclofenac Sodium Generic 18 $121
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 17 $60
Methylprednisolone Generic 11 $54
Amoxicillin Generic 12 $12

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 114 billing codes

Paid by Medicare

$157,199

Of which drugs: $6,760

Medicare patients

464

Average age 75

Services billed

2,391

317 women, 147 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Diabetes 30%
Chronic kidney disease 26%
Ischemic heart disease 24%
Depression 21%
Atrial fibrillation 17%
Heart failure 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 66 328 $245

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

127 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record